Follow
Anja Hviid Simonsen
Anja Hviid Simonsen
Senior Scientist, Dept of Neurology, Rigshospitalet
Verified email at rh.regionh.dk
Title
Cited by
Cited by
Year
Recommendations to standardize preanalytical confounding factors in Alzheimer˘s and Parkinson˘s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
3342012
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 274-284, 2017
1622017
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
AH Simonsen, J McGuire, O Hansson, H Zetterberg, VN Podust, ...
Archives of neurology 64 (3), 366-370, 2007
1622007
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
U Rüetschi, H Zetterberg, VN Podust, J Gottfries, S Li, AH Simonsen, ...
Experimental neurology 196 (2), 273-281, 2005
1482005
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ...
Alzheimer's & Dementia 13 (3), 285-295, 2017
1472017
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
AH Simonsen, J McGuire, VN Podust, H Davies, L Minthon, I Skoog, ...
Neurobiology of aging 29 (7), 961-968, 2008
1182008
The utility of á-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
AH Simonsen, B Kuiperij, OMA El-Agnaf, S Engelborghs, SK Herukka, ...
Biomarkers in medicine 10 (1), 19-34, 2016
1152016
A disease state fingerprint for evaluation of Alzheimer's disease
J Mattila, J Koikkalainen, A Virkki, A Simonsen, M Van Gils, G Waldemar, ...
Journal of Alzheimer's Disease 27 (1), 163-176, 2011
1152011
A parallel reaction monitoring mass spectrometric method for analysis of potential CSF biomarkers for Alzheimer's disease
G Brinkmalm, S Sjödin, AH Simonsen, SG Hasselbalch, H Zetterberg, ...
PROTEOMICS–Clinical Applications 12 (1), 1700131, 2018
1132018
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
A Lleó, D Alcolea, P Martínez-Lage, P Scheltens, L Parnetti, J Poirier, ...
Alzheimer's & Dementia 15 (6), 742-753, 2019
952019
Biomarkers for Alzheimer˘s disease in saliva: a systematic review
HS Gleerup, SG Hasselbalch, AH Simonsen
Disease markers 2019, 2019
912019
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer˘s disease versus normal aging and frontotemporal dementia
AH Simonsen, J McGuire, VN Podust, NO Hagnelius, TK Nilsson, ...
Dementia and geriatric cognitive disorders 24 (6), 434-440, 2007
902007
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma
CS Jensen, JM Bahl, LB Østergaard, P Høgh, L Wermuth, A Heslegrave, ...
Experimental gerontology 121, 91-98, 2019
842019
Biochemical markers of physical exercise on mild cognitive impairment and dementia: systematic review and perspectives
CS Jensen, SG Hasselbalch, G Waldemar, AH Simonsen
Frontiers in Neurology 6, 150039, 2015
842015
The potential of microRNAs as biofluid markers of neurodegenerative diseases–a systematic review
PB Danborg, AH Simonsen, G Waldemar, NHH Heegaard
Biomarkers 19 (4), 259-268, 2014
762014
Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
AL Petri, AH Simonsen, TT Yip, E Hogdall, ET Fung, L Lundvall, ...
Acta obstetricia et gynecologica Scandinavica 88 (1), 18-26, 2009
692009
Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design
K Hoffmann, KS Frederiksen, NA Sobol, N Beyer, A Vogel, AH Simonsen, ...
Neuroepidemiology 41 (3-4), 198-207, 2013
642013
Pre-analytical factors influencing the stability of cerebrospinal fluid proteins
AH Simonsen, JMC Bahl, PB Danborg, V Lindstrom, SO Larsen, A Grubb, ...
Journal of neuroscience methods 215 (2), 234-240, 2013
642013
Patients with Alzheimer's disease who carry the APOE ĺ4 allele benefit more from physical exercise
CS Jensen, AH Simonsen, V Siersma, N Beyer, KS Frederiksen, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019
602019
Cystatin C in cerebrospinal fluid and multiple sclerosis
SF Hansson, AH Simonsen, H Zetterberg, O Andersen, S Haghighi, ...
Annals of neurology 62 (2), 193-196, 2007
522007
The system can't perform the operation now. Try again later.
Articles 1–20